Prognostic value of HER3 and HER4 is preliminary studied in bladder cancer, higher soluble HER3 expression is associated with improved survival in bladder cancer, which may attribute to that sHER3 inhibits cancer cell growth and migration (Memon et al., 2004; Memon et al., 2018). Here, ERBB3 is linked to urinary bladder carcinoma.